The global market place for tailored medication is poised to achieve $3.18 trillion over the coming half-decade. While cellular and genetic therapy paradigms offer myriad benefits for biotech enterprises and their clientele, realizing treatments for patients presents numerous hurdles. Luckily, the emergence and progression of artificial intelligence arrive opportunistically to aid life sciences...

Cell and gene therapy have emerged as groundbreaking treatments for diseases once considered untreatable. These therapies focus on modifying or replacing genetic material within a patient's cells to treat or prevent disease, offering hope for conditions like cancer, genetic disorders, and rare diseases. But how can these innovative treatments become even more effective? The answer lies in...